These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 15812751)

  • 21. Early detection of epirubicin-induced cardiotoxicity in patients with breast cancer.
    Florescu M; Magda LS; Enescu OA; Jinga D; Vinereanu D
    J Am Soc Echocardiogr; 2014 Jan; 27(1):83-92. PubMed ID: 24268372
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of oral supplementation with vitamin E on the oxido-reductive status of red blood cells in normal mice and mice subject to oxidative stress by chronic administration of adriamycin.
    Thabrew MI; Samarawickrema N; Chandrasena LG; Jayasekera S
    Ann Clin Biochem; 1999 Mar; 36 ( Pt 2)():216-20. PubMed ID: 10370740
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Radionuclide ventriculography phase analysis for risk stratification of patients undergoing cardiotoxic cancer therapy.
    Jones KA; Small AD; Ray S; Hamilton DJ; Martin W; Robinson J; Goodfield NER; Paterson CA
    J Nucl Cardiol; 2022 Apr; 29(2):581-589. PubMed ID: 32748278
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Left ventricular end-diastolic volume as early indicator of trastuzumab-related cardiotoxicity in HER2+ breast cancer patients: results from a single-center retrospective study.
    Bergamini C; Torelli F; Ghiselli L; Rossi A; Trevisani L; Vinco G; Truong S; Benfari G; LA Russa F; Golia G; Molino A; Vassanelli C
    Minerva Cardioangiol; 2017 Jun; 65(3):278-287. PubMed ID: 27886160
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protection of multiple antioxidants Chinese herbal medicine on the oxidative stress induced by adriamycin chemotherapy.
    Qin XJ; He W; Hai CX; Liang X; Liu R
    J Appl Toxicol; 2008 Apr; 28(3):271-82. PubMed ID: 17582587
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Comparison of plasmatic levels of B-natriuretic peptide with echocardiographic indicators of left ventricle function after doxorubicin therapy].
    Elbl L; Vásová I; Navrátil M; Vorlícek J; Malásková L; Spinar J
    Vnitr Lek; 2006 Jun; 52(6):563-70. PubMed ID: 16871759
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Late cardiac effects of chemotherapy in breast cancer survivors treated with adjuvant doxorubicin: 10-year follow-up.
    Murtagh G; Lyons T; O'Connell E; Ballot J; Geraghty L; Fennelly D; Gullo G; Ledwidge M; Crown J; Gallagher J; Watson C; McDonald KM; Walshe JM
    Breast Cancer Res Treat; 2016 Apr; 156(3):501-506. PubMed ID: 27060913
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Two-dimensional myocardial strain imaging detects changes in left ventricular systolic function immediately after anthracycline chemotherapy.
    Stoodley PW; Richards DA; Hui R; Boyd A; Harnett PR; Meikle SR; Clarke J; Thomas L
    Eur J Echocardiogr; 2011 Dec; 12(12):945-52. PubMed ID: 21965152
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early epirubicin-induced myocardial dysfunction revealed by serial tissue Doppler echocardiography: correlation with inflammatory and oxidative stress markers.
    Mercuro G; Cadeddu C; Piras A; Dessì M; Madeddu C; Deidda M; Serpe R; Massa E; Mantovani G
    Oncologist; 2007 Sep; 12(9):1124-33. PubMed ID: 17914082
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neopterin levels and left ventricular dysfunction in patients with chronic stable angina pectoris.
    Estévez-Loureiro R; Recio-Mayoral A; Sieira-Rodríguez-Moret JA; Trallero-Araguás E; Kaski JC
    Atherosclerosis; 2009 Dec; 207(2):514-8. PubMed ID: 19577753
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Factors influencing exercise performance in patients with left ventricular dysfunction. SOLVD Investigators. Studies of Left Ventricular Dysfunction.
    Kronenberg MW; Konstam MA; Edens TR; Howe DM; Dolan N; Udelson JE; Benedict C; Stewart D; Yusuf S
    J Card Fail; 1998 Sep; 4(3):159-67. PubMed ID: 9754586
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Natriuretic peptides during the development of doxorubicin-induced left ventricular diastolic dysfunction.
    Nousiainen T; Vanninen E; Jantunen E; Puustinen J; Remes J; Rantala A; Vuolteenaho O; Hartikainen J
    J Intern Med; 2002 Mar; 251(3):228-34. PubMed ID: 11886482
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reliability of Left Ventricular Ejection Fraction from Three-Dimensional Echocardiography for Cardiotoxicity Onset Detection in Patients with Breast Cancer.
    Lorenzini C; Lamberti C; Aquilina M; Rocca A; Cortesi P; Corsi C
    J Am Soc Echocardiogr; 2017 Nov; 30(11):1103-1110. PubMed ID: 28822666
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Atorvastatin improves left ventricular systolic function and serum markers of inflammation in nonischemic heart failure.
    Sola S; Mir MQ; Lerakis S; Tandon N; Khan BV
    J Am Coll Cardiol; 2006 Jan; 47(2):332-7. PubMed ID: 16412856
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Two-dimensional speckle tracking echocardiography predicts early subclinical cardiotoxicity associated with anthracycline-trastuzumab chemotherapy in patients with breast cancer.
    Arciniegas Calle MC; Sandhu NP; Xia H; Cha SS; Pellikka PA; Ye Z; Herrmann J; Villarraga HR
    BMC Cancer; 2018 Oct; 18(1):1037. PubMed ID: 30359235
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical Utility of Longitudinal Strain to Predict Functional Recovery in Patients With Tachyarrhythmia and Reduced LVEF.
    Kusunose K; Torii Y; Yamada H; Nishio S; Hirata Y; Seno H; Saijo Y; Ise T; Yamaguchi K; Tobiume T; Yagi S; Soeki T; Wakatsuki T; Sata M
    JACC Cardiovasc Imaging; 2017 Feb; 10(2):118-126. PubMed ID: 27665160
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Left Ventricular Global Longitudinal Strain in HER-2 + Breast Cancer Patients Treated with Anthracyclines and Trastuzumab Who Develop Cardiotoxicity Is Associated with Subsequent Recovery of Left Ventricular Ejection Fraction.
    Fei HW; Ali MT; Tan TC; Cheng KH; Salama L; Hua L; Zeng X; Halpern EF; Taghian A; MacDonald SM; Scherrer-Crosbie M
    Echocardiography; 2016 Apr; 33(4):519-26. PubMed ID: 26992012
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of LVEF assessed by 2D echocardiography, gated blood pool SPECT, 99mTc tetrofosmin gated SPECT, and 18F-FDG gated PET with ERNV in patients with CAD and severe LV dysfunction.
    Raja S; Mittal BR; Santhosh S; Bhattacharya A; Rohit MK
    Nucl Med Commun; 2014 Nov; 35(11):1156-61. PubMed ID: 25144559
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardioprotective Effects of Carvedilol in Inhibiting Doxorubicin-induced Cardiotoxicity.
    Nabati M; Janbabai G; Baghyari S; Esmaili K; Yazdani J
    J Cardiovasc Pharmacol; 2017 May; 69(5):279-285. PubMed ID: 28141699
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of cardiac markers for monitoring of doxorubixin-induced cardiotoxicity in children with cancer.
    Pongprot Y; Sittiwangkul R; Charoenkwan P; Silvilairat S
    J Pediatr Hematol Oncol; 2012 Nov; 34(8):589-95. PubMed ID: 23018571
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.